Novus Biologicals™ LIS1 Antibody Blocking Peptide

Catalog No.	Quantity
NBP176815E	0.05 mg

Catalog No. NBP176815E Supplier Novus Biologicals™ Supplier No. NBP176815PEP

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 14 amino acids near the carboxy terminus of human LIS1. Source: Synthetic (Accession #: P43034) The LIS1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

• Gene ID (Entrez): 5048
• Species: Human
• Content And Storage: Store at -20 C. Avoid freeze-thaw cycles.
• Formulation: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• For Use With (Application): This Peptide is Useful as a Blocking Peptide for NBP1-76815. For Further Blocking Peptide Related Protocol, Click Here .
• Gene Alias: LIS-1, LIS1PAF-AH alpha, LIS2, lissencephaly 1 protein, Lissencephaly-1 protein, MDCR, MDS, Miller-Dieker syndrome chromosome region, PAF acetylhydrolase 45 kDa subunit, PAFAH, PAF-AH 45 kDa subunit, PAFAH alpha, PAFAHA, platelet-activating factor acetylhydrolase 1 b, regulatory subunit 1 (45 kDa), platelet-activating factor acetylhydrolase IB subunit alpha, platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit (45 kD), platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit 45 kDa, platelet-activating factor acetylhydrolase, isoform Ib, subunit 1 (45 kDa)
• Gene Symbol: PAFAH1B1
• Product Type: LIS1
• Quantity: 0.05 mg
• Regulatory Status: RUO - research use only
• Source: Synthetic
• Termination: 14 amino acids near the carboxy terminus of human LIS1